![Emile van Dongen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Emile van Dongen
Amministratore Delegato presso Progress Pharma NV
Posizioni attive di Emile van Dongen
Società | Posizione | Inizio | Fine |
---|---|---|---|
Organon BioSciences NV
![]() Organon BioSciences NV Pharmaceuticals: MajorHealth Technology Organon Biosciences NV specializes in biopharmaceutical manufacturing and distribution services. It develops products in the areas of cardiovascular disease, fertility, gynecology, anesthesia, respiratory, consumer health care, and neuroscience, immunology, animal health, and oncology. The company’s products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, cold/flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. It was founded in 1923 and is headquartered in Oss, the Netherlands. | Vendite & Marketing | - | - |
Progress Pharma NV
![]() Progress Pharma NV BiotechnologyHealth Technology Progress Pharma NV adopts a business model for asset-centric drug development. The company is headquartered in Vosselaar, Belgium. | Amministratore Delegato | - | - |
Storia della carriera di Emile van Dongen
Precedenti posizioni note di Emile van Dongen
Società | Posizione | Inizio | Fine |
---|---|---|---|
Movetis NV
![]() Movetis NV Pharmaceuticals: GenericHealth Technology Movetis NV operates as a pharmaceutical company, that focuses on the discovery, development, and commercialization of drugs for the treatment of diseases in the gastrointestinal (GI) area. Its products address GI disorders, such as severe chronic constipation, ascites, and paediatric reflux, as well as severe forms of GI motility disorders, including refractory gastro-oesophageal reflux disease. The company was founded in November 2006 and is headquartered in Turnhout, Belgium. | Direttore/Membro del Consiglio | 18/09/2009 | - |
Organon International, Inc.
![]() Organon International, Inc. Pharmaceuticals: MajorHealth Technology Organon International, Inc. manufactures and markets pharmaceutical products. It develops therapeutics in the fields such as gynecology, fertility, osteoporosis, and anesthesia. The company was founded in 1923 and is located in Roseland, NJ. | Vendite & Marketing | 01/01/1983 | - |
Formazione di Emile van Dongen
University of Georgia | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 3 |
Belgio | 3 |
Paesi Bassi | 2 |
Posizioni
Sales & Marketing | 2 |
Masters Business Admin | 1 |
Director/Board Member | 1 |
Settori
Health Technology | 5 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 4 |
---|---|
Organon International, Inc.
![]() Organon International, Inc. Pharmaceuticals: MajorHealth Technology Organon International, Inc. manufactures and markets pharmaceutical products. It develops therapeutics in the fields such as gynecology, fertility, osteoporosis, and anesthesia. The company was founded in 1923 and is located in Roseland, NJ. | Health Technology |
Organon BioSciences NV
![]() Organon BioSciences NV Pharmaceuticals: MajorHealth Technology Organon Biosciences NV specializes in biopharmaceutical manufacturing and distribution services. It develops products in the areas of cardiovascular disease, fertility, gynecology, anesthesia, respiratory, consumer health care, and neuroscience, immunology, animal health, and oncology. The company’s products include mometasone furoate inhalation powder, moxifloxacin, pegylated liposomal doxorubicin HCI, desogestrel, desloratadine, sun care, cold/flu medicine, foot care, follitropin beta, formoterol fumarate inhalation powder, hormone therapy, and canine vaccines. It was founded in 1923 and is headquartered in Oss, the Netherlands. | Health Technology |
Movetis NV
![]() Movetis NV Pharmaceuticals: GenericHealth Technology Movetis NV operates as a pharmaceutical company, that focuses on the discovery, development, and commercialization of drugs for the treatment of diseases in the gastrointestinal (GI) area. Its products address GI disorders, such as severe chronic constipation, ascites, and paediatric reflux, as well as severe forms of GI motility disorders, including refractory gastro-oesophageal reflux disease. The company was founded in November 2006 and is headquartered in Turnhout, Belgium. | Health Technology |
Progress Pharma NV
![]() Progress Pharma NV BiotechnologyHealth Technology Progress Pharma NV adopts a business model for asset-centric drug development. The company is headquartered in Vosselaar, Belgium. | Health Technology |
- Borsa valori
- Insiders
- Emile van Dongen
- Esperienza